img

Global Medical Antifungal Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medical Antifungal Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antifungals are medicines that kill or stop the growth of fungi that cause infections.
Medical Antifungal Agent report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Antifungal Agent market is projected to reach US$ 16170 million in 2029, increasing from US$ 13030 million in 2022, with the CAGR of 2.9% during the period of 2024 to 2029. Demand from Dermatophytosis and Aspergillosis are the major drivers for the industry.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Antifungal Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology
Segment by Type
Azoles
Echinocandins
Polyenes
Allylamines
Others

Segment by Application


Dermatophytosis
Aspergillosis
Candidiasis
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Antifungal Agent market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Antifungal Agent, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Antifungal Agent industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Antifungal Agent in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Antifungal Agent introduction, etc. Medical Antifungal Agent Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Medical Antifungal Agent market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Medical Antifungal Agent Market Overview
1.1 Medical Antifungal Agent Product Overview
1.2 Medical Antifungal Agent Market Segment by Type
1.2.1 Azoles
1.2.2 Echinocandins
1.2.3 Polyenes
1.2.4 Allylamines
1.2.5 Others
1.3 Global Medical Antifungal Agent Market Size by Type
1.3.1 Global Medical Antifungal Agent Market Size Overview by Type (2018-2029)
1.3.2 Global Medical Antifungal Agent Historic Market Size Review by Type (2018-2024)
1.3.3 Global Medical Antifungal Agent Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Medical Antifungal Agent Sales Breakdown by Type (2018-2024)
1.4.2 Europe Medical Antifungal Agent Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Medical Antifungal Agent Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Medical Antifungal Agent Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Medical Antifungal Agent Sales Breakdown by Type (2018-2024)
2 Global Medical Antifungal Agent Market Competition by Company
2.1 Global Top Players by Medical Antifungal Agent Sales (2018-2024)
2.2 Global Top Players by Medical Antifungal Agent Revenue (2018-2024)
2.3 Global Top Players by Medical Antifungal Agent Price (2018-2024)
2.4 Global Top Manufacturers Medical Antifungal Agent Manufacturing Base Distribution, Sales Area, Product Type
2.5 Medical Antifungal Agent Market Competitive Situation and Trends
2.5.1 Medical Antifungal Agent Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Medical Antifungal Agent Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Antifungal Agent as of 2022)
2.7 Date of Key Manufacturers Enter into Medical Antifungal Agent Market
2.8 Key Manufacturers Medical Antifungal Agent Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Medical Antifungal Agent Status and Outlook by Region
3.1 Global Medical Antifungal Agent Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Medical Antifungal Agent Historic Market Size by Region
3.2.1 Global Medical Antifungal Agent Sales in Volume by Region (2018-2024)
3.2.2 Global Medical Antifungal Agent Sales in Value by Region (2018-2024)
3.2.3 Global Medical Antifungal Agent Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Medical Antifungal Agent Forecasted Market Size by Region
3.3.1 Global Medical Antifungal Agent Sales in Volume by Region (2024-2029)
3.3.2 Global Medical Antifungal Agent Sales in Value by Region (2024-2029)
3.3.3 Global Medical Antifungal Agent Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Medical Antifungal Agent by Application
4.1 Medical Antifungal Agent Market Segment by Application
4.1.1 Dermatophytosis
4.1.2 Aspergillosis
4.1.3 Candidiasis
4.1.4 Others
4.2 Global Medical Antifungal Agent Market Size by Application
4.2.1 Global Medical Antifungal Agent Market Size Overview by Application (2018-2029)
4.2.2 Global Medical Antifungal Agent Historic Market Size Review by Application (2018-2024)
4.2.3 Global Medical Antifungal Agent Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Medical Antifungal Agent Sales Breakdown by Application (2018-2024)
4.3.2 Europe Medical Antifungal Agent Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Medical Antifungal Agent Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Medical Antifungal Agent Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Medical Antifungal Agent Sales Breakdown by Application (2018-2024)
5 North America Medical Antifungal Agent by Country
5.1 North America Medical Antifungal Agent Historic Market Size by Country
5.1.1 North America Medical Antifungal Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Medical Antifungal Agent Sales in Volume by Country (2018-2024)
5.1.3 North America Medical Antifungal Agent Sales in Value by Country (2018-2024)
5.2 North America Medical Antifungal Agent Forecasted Market Size by Country
5.2.1 North America Medical Antifungal Agent Sales in Volume by Country (2024-2029)
5.2.2 North America Medical Antifungal Agent Sales in Value by Country (2024-2029)
6 Europe Medical Antifungal Agent by Country
6.1 Europe Medical Antifungal Agent Historic Market Size by Country
6.1.1 Europe Medical Antifungal Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Medical Antifungal Agent Sales in Volume by Country (2018-2024)
6.1.3 Europe Medical Antifungal Agent Sales in Value by Country (2018-2024)
6.2 Europe Medical Antifungal Agent Forecasted Market Size by Country
6.2.1 Europe Medical Antifungal Agent Sales in Volume by Country (2024-2029)
6.2.2 Europe Medical Antifungal Agent Sales in Value by Country (2024-2029)
7 Asia-Pacific Medical Antifungal Agent by Region
7.1 Asia-Pacific Medical Antifungal Agent Historic Market Size by Region
7.1.1 Asia-Pacific Medical Antifungal Agent Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Medical Antifungal Agent Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Medical Antifungal Agent Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Medical Antifungal Agent Forecasted Market Size by Region
7.2.1 Asia-Pacific Medical Antifungal Agent Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Medical Antifungal Agent Sales in Value by Region (2024-2029)
8 Latin America Medical Antifungal Agent by Country
8.1 Latin America Medical Antifungal Agent Historic Market Size by Country
8.1.1 Latin America Medical Antifungal Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Medical Antifungal Agent Sales in Volume by Country (2018-2024)
8.1.3 Latin America Medical Antifungal Agent Sales in Value by Country (2018-2024)
8.2 Latin America Medical Antifungal Agent Forecasted Market Size by Country
8.2.1 Latin America Medical Antifungal Agent Sales in Volume by Country (2024-2029)
8.2.2 Latin America Medical Antifungal Agent Sales in Value by Country (2024-2029)
9 Middle East and Africa Medical Antifungal Agent by Country
9.1 Middle East and Africa Medical Antifungal Agent Historic Market Size by Country
9.1.1 Middle East and Africa Medical Antifungal Agent Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Medical Antifungal Agent Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Medical Antifungal Agent Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Medical Antifungal Agent Forecasted Market Size by Country
9.2.1 Middle East and Africa Medical Antifungal Agent Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Medical Antifungal Agent Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Medical Antifungal Agent Products Offered
10.1.5 Novartis Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Medical Antifungal Agent Products Offered
10.2.5 Pfizer Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer Medical Antifungal Agent Products Offered
10.3.5 Bayer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi Medical Antifungal Agent Products Offered
10.4.5 Sanofi Recent Development
10.5 Merck & Co
10.5.1 Merck & Co Company Information
10.5.2 Merck & Co Introduction and Business Overview
10.5.3 Merck & Co Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Merck & Co Medical Antifungal Agent Products Offered
10.5.5 Merck & Co Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.6.4 GlaxoSmithKline Medical Antifungal Agent Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 MSD Manuals
10.7.1 MSD Manuals Company Information
10.7.2 MSD Manuals Introduction and Business Overview
10.7.3 MSD Manuals Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.7.4 MSD Manuals Medical Antifungal Agent Products Offered
10.7.5 MSD Manuals Recent Development
10.8 Abbott
10.8.1 Abbott Company Information
10.8.2 Abbott Introduction and Business Overview
10.8.3 Abbott Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Abbott Medical Antifungal Agent Products Offered
10.8.5 Abbott Recent Development
10.9 Glenmark
10.9.1 Glenmark Company Information
10.9.2 Glenmark Introduction and Business Overview
10.9.3 Glenmark Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Glenmark Medical Antifungal Agent Products Offered
10.9.5 Glenmark Recent Development
10.10 Enzon Pharmaceuticals
10.10.1 Enzon Pharmaceuticals Company Information
10.10.2 Enzon Pharmaceuticals Introduction and Business Overview
10.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Products Offered
10.10.5 Enzon Pharmaceuticals Recent Development
10.11 Astellas Pharma
10.11.1 Astellas Pharma Company Information
10.11.2 Astellas Pharma Introduction and Business Overview
10.11.3 Astellas Pharma Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Astellas Pharma Medical Antifungal Agent Products Offered
10.11.5 Astellas Pharma Recent Development
10.12 Scynexis
10.12.1 Scynexis Company Information
10.12.2 Scynexis Introduction and Business Overview
10.12.3 Scynexis Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Scynexis Medical Antifungal Agent Products Offered
10.12.5 Scynexis Recent Development
10.13 Cidara Therapeutics
10.13.1 Cidara Therapeutics Company Information
10.13.2 Cidara Therapeutics Introduction and Business Overview
10.13.3 Cidara Therapeutics Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Cidara Therapeutics Medical Antifungal Agent Products Offered
10.13.5 Cidara Therapeutics Recent Development
10.14 Lucigen Corporation
10.14.1 Lucigen Corporation Company Information
10.14.2 Lucigen Corporation Introduction and Business Overview
10.14.3 Lucigen Corporation Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Lucigen Corporation Medical Antifungal Agent Products Offered
10.14.5 Lucigen Corporation Recent Development
10.15 Biosergen
10.15.1 Biosergen Company Information
10.15.2 Biosergen Introduction and Business Overview
10.15.3 Biosergen Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Biosergen Medical Antifungal Agent Products Offered
10.15.5 Biosergen Recent Development
10.16 F2G
10.16.1 F2G Company Information
10.16.2 F2G Introduction and Business Overview
10.16.3 F2G Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.16.4 F2G Medical Antifungal Agent Products Offered
10.16.5 F2G Recent Development
10.17 Sichuan Meidakang Pharmaceutical
10.17.1 Sichuan Meidakang Pharmaceutical Company Information
10.17.2 Sichuan Meidakang Pharmaceutical Introduction and Business Overview
10.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Products Offered
10.17.5 Sichuan Meidakang Pharmaceutical Recent Development
10.18 Chengdu Taihe Health Technology
10.18.1 Chengdu Taihe Health Technology Company Information
10.18.2 Chengdu Taihe Health Technology Introduction and Business Overview
10.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Products Offered
10.18.5 Chengdu Taihe Health Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Medical Antifungal Agent Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Medical Antifungal Agent Industrial Chain Analysis
11.4 Medical Antifungal Agent Market Dynamics
11.4.1 Medical Antifungal Agent Industry Trends
11.4.2 Medical Antifungal Agent Market Drivers
11.4.3 Medical Antifungal Agent Market Challenges
11.4.4 Medical Antifungal Agent Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Medical Antifungal Agent Distributors
12.3 Medical Antifungal Agent Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Azoles
Table 2. Major Company of Echinocandins
Table 3. Major Company of Polyenes
Table 4. Major Company of Allylamines
Table 5. Major Company of Others
Table 6. Global Medical Antifungal Agent Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 8. Global Medical Antifungal Agent Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Medical Antifungal Agent Sales by Type (2018-2024) & (US& Million)
Table 10. Global Medical Antifungal Agent Market Share in Value by Type (2018-2024)
Table 11. Global Medical Antifungal Agent Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Medical Antifungal Agent Sales by Type (2024-2029) & (K Units)
Table 13. Global Medical Antifungal Agent Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Medical Antifungal Agent Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Medical Antifungal Agent Sales Market Share in Value by Type (2024-2029)
Table 16. Global Medical Antifungal Agent Price by Type (2024-2029) & (US$/Unit)
Table 17. North America Medical Antifungal Agent Sales by Type (2018-2024) & (K Units)
Table 18. North America Medical Antifungal Agent Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Medical Antifungal Agent Sales (K Units) by Type (2018-2024)
Table 20. Europe Medical Antifungal Agent Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Medical Antifungal Agent Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Medical Antifungal Agent Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Medical Antifungal Agent Sales (K Units) by Type (2018-2024)
Table 24. Latin America Medical Antifungal Agent Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Medical Antifungal Agent Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Medical Antifungal Agent Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Medical Antifungal Agent Sales by Company (2018-2024) & (K Units)
Table 28. Global Medical Antifungal Agent Sales Share by Company (2018-2024)
Table 29. Global Medical Antifungal Agent Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Medical Antifungal Agent Revenue Share by Company (2018-2024)
Table 31. Global Market Medical Antifungal Agent Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Medical Antifungal Agent Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Medical Antifungal Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Antifungal Agent as of 2022)
Table 35. Date of Key Manufacturers Enter into Medical Antifungal Agent Market
Table 36. Key Manufacturers Medical Antifungal Agent Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Medical Antifungal Agent Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Medical Antifungal Agent Sales by Region (2018-2024) & (K Units)
Table 40. Global Medical Antifungal Agent Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Medical Antifungal Agent Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Medical Antifungal Agent Sales Market Share in Value by Region (2018-2024)
Table 43. Global Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Medical Antifungal Agent Sales by Region (2024-2029) & (K Units)
Table 45. Global Medical Antifungal Agent Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Medical Antifungal Agent Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Medical Antifungal Agent Sales Market Share in Value by Region (2024-2029)
Table 48. Global Medical Antifungal Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global Medical Antifungal Agent Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Medical Antifungal Agent Sales by Application (2018-2024) & (K Units)
Table 51. Global Medical Antifungal Agent Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Medical Antifungal Agent Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Medical Antifungal Agent Sales Market Share in Value by Application (2018-2024)
Table 54. Global Medical Antifungal Agent Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Medical Antifungal Agent Sales by Application (2024-2029) & (K Units)
Table 56. Global Medical Antifungal Agent Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Medical Antifungal Agent Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Medical Antifungal Agent Sales Market Share in Value by Application (2024-2029)
Table 59. Global Medical Antifungal Agent Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Medical Antifungal Agent Sales by Application (2018-2024) (K Units)
Table 61. North America Medical Antifungal Agent Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Medical Antifungal Agent Sales by Application (2018-2024) (K Units)
Table 63. Europe Medical Antifungal Agent Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Medical Antifungal Agent Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Medical Antifungal Agent Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Medical Antifungal Agent Sales by Application (2018-2024) (K Units)
Table 67. Latin America Medical Antifungal Agent Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Medical Antifungal Agent Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Medical Antifungal Agent Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 71. North America Medical Antifungal Agent Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Medical Antifungal Agent Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Medical Antifungal Agent Sales Market Share in Value by Country (2018-2024)
Table 74. North America Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 75. North America Medical Antifungal Agent Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Medical Antifungal Agent Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Medical Antifungal Agent Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 79. Europe Medical Antifungal Agent Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Medical Antifungal Agent Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Medical Antifungal Agent Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 83. Europe Medical Antifungal Agent Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Medical Antifungal Agent Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Medical Antifungal Agent Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Medical Antifungal Agent Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Medical Antifungal Agent Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Medical Antifungal Agent Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Medical Antifungal Agent Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Medical Antifungal Agent Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Medical Antifungal Agent Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Medical Antifungal Agent Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Medical Antifungal Agent Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Medical Antifungal Agent Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Medical Antifungal Agent Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Medical Antifungal Agent Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 99. Latin America Medical Antifungal Agent Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Medical Antifungal Agent Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Medical Antifungal Agent Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Medical Antifungal Agent Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Medical Antifungal Agent Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Medical Antifungal Agent Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Medical Antifungal Agent Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Medical Antifungal Agent Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa Medical Antifungal Agent Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Medical Antifungal Agent Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Medical Antifungal Agent Sales Market Share in Value by Country (2024-2029)
Table 110. Novartis Company Information
Table 111. Novartis Introduction and Business Overview
Table 112. Novartis Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novartis Medical Antifungal Agent Product
Table 114. Novartis Recent Development
Table 115. Pfizer Company Information
Table 116. Pfizer Introduction and Business Overview
Table 117. Pfizer Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Pfizer Medical Antifungal Agent Product
Table 119. Pfizer Recent Development
Table 120. Bayer Company Information
Table 121. Bayer Introduction and Business Overview
Table 122. Bayer Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Bayer Medical Antifungal Agent Product
Table 124. Bayer Recent Development
Table 125. Sanofi Company Information
Table 126. Sanofi Introduction and Business Overview
Table 127. Sanofi Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Sanofi Medical Antifungal Agent Product
Table 129. Sanofi Recent Development
Table 130. Merck & Co Company Information
Table 131. Merck & Co Introduction and Business Overview
Table 132. Merck & Co Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Merck & Co Medical Antifungal Agent Product
Table 134. Merck & Co Recent Development
Table 135. GlaxoSmithKline Company Information
Table 136. GlaxoSmithKline Introduction and Business Overview
Table 137. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. GlaxoSmithKline Medical Antifungal Agent Product
Table 139. GlaxoSmithKline Recent Development
Table 140. MSD Manuals Company Information
Table 141. MSD Manuals Introduction and Business Overview
Table 142. MSD Manuals Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. MSD Manuals Medical Antifungal Agent Product
Table 144. MSD Manuals Recent Development
Table 145. Abbott Company Information
Table 146. Abbott Introduction and Business Overview
Table 147. Abbott Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Abbott Medical Antifungal Agent Product
Table 149. Abbott Recent Development
Table 150. Glenmark Company Information
Table 151. Glenmark Introduction and Business Overview
Table 152. Glenmark Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Glenmark Medical Antifungal Agent Product
Table 154. Glenmark Recent Development
Table 155. Enzon Pharmaceuticals Company Information
Table 156. Enzon Pharmaceuticals Introduction and Business Overview
Table 157. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Enzon Pharmaceuticals Medical Antifungal Agent Product
Table 159. Enzon Pharmaceuticals Recent Development
Table 160. Astellas Pharma Company Information
Table 161. Astellas Pharma Introduction and Business Overview
Table 162. Astellas Pharma Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Astellas Pharma Medical Antifungal Agent Product
Table 164. Astellas Pharma Recent Development
Table 165. Scynexis Company Information
Table 166. Scynexis Introduction and Business Overview
Table 167. Scynexis Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Scynexis Medical Antifungal Agent Product
Table 169. Scynexis Recent Development
Table 170. Cidara Therapeutics Company Information
Table 171. Cidara Therapeutics Introduction and Business Overview
Table 172. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Cidara Therapeutics Medical Antifungal Agent Product
Table 174. Cidara Therapeutics Recent Development
Table 175. Lucigen Corporation Company Information
Table 176. Lucigen Corporation Introduction and Business Overview
Table 177. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Lucigen Corporation Medical Antifungal Agent Product
Table 179. Lucigen Corporation Recent Development
Table 180. Biosergen Company Information
Table 181. Biosergen Introduction and Business Overview
Table 182. Biosergen Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Biosergen Medical Antifungal Agent Product
Table 184. Biosergen Recent Development
Table 185. F2G Company Information
Table 186. F2G Introduction and Business Overview
Table 187. F2G Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. F2G Medical Antifungal Agent Product
Table 189. F2G Recent Development
Table 190. Sichuan Meidakang Pharmaceutical Company Information
Table 191. Sichuan Meidakang Pharmaceutical Introduction and Business Overview
Table 192. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product
Table 194. Sichuan Meidakang Pharmaceutical Recent Development
Table 195. Chengdu Taihe Health Technology Company Information
Table 196. Chengdu Taihe Health Technology Introduction and Business Overview
Table 197. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. Chengdu Taihe Health Technology Medical Antifungal Agent Product
Table 199. Chengdu Taihe Health Technology Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Medical Antifungal Agent Market Trends
Table 203. Medical Antifungal Agent Market Drivers
Table 204. Medical Antifungal Agent Market Challenges
Table 205. Medical Antifungal Agent Market Restraints
Table 206. Medical Antifungal Agent Distributors List
Table 207. Medical Antifungal Agent Downstream Customers
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Antifungal Agent Product Picture
Figure 2. Global Medical Antifungal Agent Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Medical Antifungal Agent Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Medical Antifungal Agent Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Azoles
Figure 6. Global Azoles Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Echinocandins
Figure 8. Global Echinocandins Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Polyenes
Figure 10. Global Polyenes Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Allylamines
Figure 12. Global Allylamines Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global Medical Antifungal Agent Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Medical Antifungal Agent Sales Market Share by Type in 2022 & 2029
Figure 17. North America Medical Antifungal Agent Sales Market Share in Volume by Type in 2022
Figure 18. North America Medical Antifungal Agent Sales Market Share in Value by Type in 2022
Figure 19. Europe Medical Antifungal Agent Sales Market Share in Volume by Type in 2022
Figure 20. Europe Medical Antifungal Agent Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Medical Antifungal Agent Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Medical Antifungal Agent Sales Market Share in Value by Type in 2022
Figure 23. Latin America Medical Antifungal Agent Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Medical Antifungal Agent Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Medical Antifungal Agent Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Medical Antifungal Agent Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Antifungal Agent Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Antifungal Agent Revenue in 2022
Figure 29. Medical Antifungal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Dermatophytosis
Figure 31. Global Dermatophytosis Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Aspergillosis
Figure 33. Global Aspergillosis Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Candidiasis
Figure 35. Global Candidiasis Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Global Medical Antifungal Agent Sales by Application (2018-2029) & (US$ Million)
Figure 39. Global Medical Antifungal Agent Sales Market Share by Application in 2022 & 2029
Figure 40. North America Medical Antifungal Agent Sales Market Share in Volume by Application in 2022
Figure 41. North America Medical Antifungal Agent Sales Market Share in Value by Application in 2022
Figure 42. Europe Medical Antifungal Agent Sales Market Share in Volume by Application in 2022
Figure 43. Europe Medical Antifungal Agent Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Medical Antifungal Agent Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Medical Antifungal Agent Sales Market Share in Value by Application in 2022
Figure 46. Latin America Medical Antifungal Agent Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Medical Antifungal Agent Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Medical Antifungal Agent Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Medical Antifungal Agent Manufacturing Cost Structure
Figure 51. Medical Antifungal Agent Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed